脂联素对慢性心力衰竭伴糖尿病患者的影响

被引:3
作者
吴穷
苏倩
任妍
虞莹珺
张凤如
机构
[1] 上海交通大学医学院附属瑞金医院老年科
关键词
脂联素; 心力衰竭; 糖尿病;
D O I
暂无
中图分类号
R541.6 [血液循环衰竭];
学科分类号
1002 ; 100201 ;
摘要
目的:探讨脂联素与心力衰竭(心衰)患者心功能、前脑钠肽(pro-BNP)及高敏C反应蛋白(hs-CRP)等生化及生物标志物指标的相关性,以及脂联素与心衰尤其是合并糖尿病者预后的关系。方法:选择慢性心衰患者203例,分为伴有糖尿病组93例和不伴有糖尿病组110例。健康对照组60名。将患者全因死亡、猝死作为终点事件,随访1年,采用酶联免疫吸附法测定其血清脂联素、pro-BNP及hs-CRP水平。结果:心衰组脂联素水平较正常对照组明显升高(P<0.01),心衰伴糖尿病组较心衰不伴糖尿病组脂联素水平有所下降(P<0.05)。体质量指数(BMI)、心功能分级、慢性肾功能不全、pro-BNP、三酰甘油(TG)及高密度脂蛋白(HDL)是脂联素水平的独立影响因素。脂联素是心衰病死率的独立预测因子(P<0.05)。结论:慢性心衰患者血清脂联素水平明显升高,且与心衰严重程度(心功能分级)正相关,但伴有糖尿病者脂联素水平有所降低,脂联素是慢性心衰患者预后的独立预测因子。
引用
收藏
页码:29 / 33
页数:5
相关论文
共 8 条
[1]  
Plasma adiponectin, body massindex, and mortality in patients with chronic heart failure. Kistorp C,Faber J,Galatius S, et al. Circulation . 2005
[2]  
Adiponectin in chron-ic heart failure:influence of diabetes and genetic variants. Masson S,Gori F,Latini R,et al. European Journal of Clinical Investigation . 2011
[3]  
Plasma adiponectinconcentration and its association with metabolic syn-drome in patients with heart failure. Won H,Kang SM,Shin MJ,et al. Yonsei Medical Journal . 2012
[4]  
Circulatingadiponectin concentrations in patients with congestiveheart failure. George J,Patal S,Wexler D,et al. Heart . 2006
[5]  
Circu-lating adiponectin levels and mortality in elderly menwith and without cardiovascular disease and heart failure. Wannamethee SG,Whincup PH,Lennon L,et al. Archives of Internal Medicine . 2007
[6]  
Elevated adiponectin levels in pa-tients with chronic heart failure:an independent predictorof mortality or a marker of cardiac cachexia?. Celik T,Yaman H. International Journal of Cardiology . 2010
[7]  
Relationship ofadiponectin with markers of systemic inflammation,atherogenicdyslipidemia,and heart failure in patients with coronary heartdisease. von-Eynatten M,Hamann A,Twardella D,et al. Clin-Chem . 2006
[8]  
Adiponectin isreleased from the heart in patients with heart failure. Takano H,Obata JE,Kodama Y,et al. International Journal of Cardiology . 2009